and pharma by a start up in zurich switzerland thomas developers and his team are developing an alternative to fecal transplants they use mixtures of intestinal bacteria to produce targeted therapies for a number of different diseases. if we want to package the kind of effect seen in fecal transplants into medication to scale it up so it can be manufactured to ensure it's safe the aim is to give each patient the mixture that will help them the most. ready specific kinds of bacteria are extracted from human feces ready. this has to be done in an anaerobic chamber because most gut bacteria can survive when exposed to oxygen. these microbes can there be cultivated and eventually put together in various combinations to recreate healthy gut flora. but 1st the various species require a lot of cat if they are to flourish. the biggest headache is that the different bacteria need very different nutrients we've therefore developed a huge range of different growth media in order to cover the disparate needs of the bacteria and then be able to cultivate them individually. it's called dave you're. ready

and pharma by a start up in zurich switzerland thomas developers and his team are developing an alternative to fecal transplants they use mixtures of intestinal bacteria to produce targeted therapies for a number of different diseases. effect we want to package the kind of effect seen in fecal transplants into medication to scale it up so it can be manufactured to ensure it's safe the aim is to give each patient the mixture that will help them the most. ready specific kinds of bacteria are extracted from human feces ready. this has to be done in an aerobic chamber because most gut bacteria can survive when exposed to oxygen. these microbes can then be cultivated and eventually put together in various combinations to recreate healthy gut flora. but 1st the various species require a lot of care if they are to flourish. the biggest headache is that the different bacteria need very different nutrients and we've therefore developed a huge range of different growth media in order to cover the disparate needs of the bacteria and then be able to cultivate them individually. it's cool to hear. ready

and pharma by a start up in zurich switzerland thomas developers and his team are developing an alternative to fecal transplants they use mixtures of intestinal bacteria to produce targeted therapies for a number of different diseases. effect we want to package the kind of effect seen and fecal transplants into medication to scale it up so it can be manufactured to ensure it's safe the aim is to give each patient the mixture that will help them the most. specific kinds of bacteria are extracted from human feces. this has to be done in an anaerobic chamber because most gut bacteria can survive when exposed to oxygen. these microbes can then be cultivated and eventually put together in various combinations to recreate healthy gut flora. but 1st the various species require a lot of care if they are to flourish. the biggest headache is that the different bacteria need very different nutrients and we've therefore developed a huge range of different growth media in order to cover the disparate needs of the bacteria and then be able to cultivate them individually. it's cool to hear. the team studi

and pharma by a start up in zurich switzerland thomas developers and his team are developing an alternative to fecal transplants they use mixtures of intestinal bacteria to produce targeted therapies for a number of different diseases. it's the effect we want to package the kind of effect seen in fecal transplants into medication to scale it up so it can be manufactured to ensure it's safe the aim is to give each patient the mixture but will help them the most. specific kinds of bacteria are extracted from human feces. this has to be done in an aerobic chamber because most gut bacteria can survive when exposed to oxygen. these microbes can then be cultivated and eventually put together in various combinations to recreate a healthy gut flora. but 1st the various species require a lot of care if they are to flourish. the biggest headache is that the different bacteria need very different nutrients and we've therefore developed a huge range of different growth media in order to cover the disparate needs of the bacteria and then be able to cultivate them individually. it's cool to hear. the tea

and pharma by a start up in zurich switzerland thomas developers and his team are developing an alternative to fecal transplants they use mixtures of intestinal bacteria to produce targeted therapies for a number of different diseases. effect we want to package the kind of effect seen and fecal transplants into medication to scale it up so it can be manufactured to ensure it's safe the aim is to give each patient the mixture that will help them the most. ready specific kinds of bacteria are extracted from human feces ready. this has to be done in an anaerobic chamber because most gut bacteria can survive when exposed to oxygen. these microbes can then be cultivated and eventually put together in various combinations to recreate healthy gut flora. but 1st the various species require a lot of cat if they are to flourish. the biggest headache is that the different bacteria need very different nutrients we've therefore developed a huge range of different growth media in order to cover the disparate needs of the bacteria and then be able to cultivate them individually. it's cool to hear. the tea